Clinical trial
A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment…
NCT00308191 · Dey, Industry · Completed
Key facts
| NCT number | NCT00308191 |
|---|---|
| Title | A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD |
| Official title | A 6-Week Double-Blind, Parallel-Group, Active-Controlled Trial to Compare the Efficacy and Safety of Concomitant Treatment of Formoterol Fumarate Inhalation Solution 20 Mcg Twice Daily and Tiotropium 18 Mcg Once Daily to Tiotropium 18 Mcg Once Daily Alone in the Treatment of Patients With Chronic… |
| Lead sponsor | Dey, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | Formoterol Fumarate, Tiotropium Bromide |
| Enrollment | 128 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 29, 2006 |
| Last update posted | Mar 7, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: